Dark

PBE
Invesco Biotechnology & Genome ETF
stock NYSE ETF

Market Open

Aug 3, 2026 3:21:23 PM EDT

90.27USD+0.736%(+0.66)657,333

90.18Bid 90.55Ask 0.37Spread

Pre-market

0.00USD-100.000%(-91.10)0

After-hours

Jul 31, 2026 4:10:30 PM EDT

89.61USD-0.322%(-0.29)0

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

283.42M

Headquarters

IL, USA

Last Dividend

Sep 24, 20180.002

PBE Stats

Avg. Vol. 10 Day

5,491

Avg. Vol. 30 Day

7,433

Market Cap

283,416,400

Shares Out.

3,140,000

On/Off Exchange

8%/92%

6 Month Beta

0.61

1 Year Beta

0.59

2 Year Beta

0.73

3 Year Beta

0.75

52 Week Low

64.60

52 Week High

94.06

SMA50

87.24

SMA200

81.71

1 Week

+0.46%

1 Month

-1.94%

3 Month

+12.28%

6 Month

+9.06%

1 Year

+35.70%

2 Year

+31.82%

5 Year

+18.48%

Profile

The investment seeks to track the investment results (before fees and expenses) of the Dynamic Biotech & Genome IntellidexSM Index. The fund generally will invest at least 90% of its total assets in common stocks of biotechnology companies and genome companies that comprise the underlying intellidex. The underlying intellidex was composed of common stocks of 30 U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.

PBE Stock Summary

Invesco Biotechnology & Genome ETF (NYSE:PBE) stock price today is $90.27, and today's volume is 657,333. PBE is up 0.736% today. The 30 day average volume is 7,433. PBE market cap is 283.42M with 3,140,000 shares outstanding.